drugset / Trial / NCT02192723
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the efficacy and side effects of 6 commonly used antipsychotic drugs in the treatment of schizophrenia in a Chinese population.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | — |
| Subject | Aripiprazole | Other / unclassified | 30 mg | — |
| Subject | Haloperidol | Other / unclassified | 6 mg | — |
| Subject | Haloperidol | Other / unclassified | 20 mg | — |
| Comparator | Olanzapine | Small molecule | 400 mg | — |
| Comparator | Olanzapine | Small molecule | 750 mg | — |
| Subject | Perphenazine | Small molecule | 16 mg | — |
| Subject | Perphenazine | Small molecule | 64 mg | — |
| Comparator | Quetiapine | Small molecule | 400 mg | — |
| Comparator | Quetiapine | Small molecule | 750 mg | — |
| Comparator | Risperidone | Other / unclassified | 2 mg | — |
| Comparator | Risperidone | Other / unclassified | 6 mg | — |
| Comparator | Ziprasidone | Small molecule | 80 mg | — |
| Comparator | Ziprasidone | Small molecule | 160 mg | — |